Sensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
Amgen, Inc. is recalling Sensipar (cinacalcet) 60 mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects 30-count bottles with Lot #1157055 and expiration date 1/31/2028.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as Class II. The source does not report any hospitalization, deaths, serious injuries, or confirmed adverse health consequences. CGMP deviations represent a potential manufacturing control issue without demonstrated patient harm, placing this within the Moderate category.
Plain-English summary
Amgen, Inc. is recalling Sensipar (cinacalcet hydrochloride) 60 mg tablets distributed nationwide in the United States. The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing. The affected product is distributed in 30-count bottles, NDC 55513-074-30, with Lot #1157055 and expiration date 1/31/2028.
This is a Class II recall initiated voluntarily by the firm. Patients taking this medication should not stop taking their prescription without consulting their healthcare provider. Patients who have this lot should contact their pharmacy or healthcare provider for guidance on obtaining an unaffected supply or alternative treatment.
The recalled product
- Product
- SENSIPAR (CINACALCET HYDROCHLORIDE)
- Brand
- SENSIPAR
- Manufacturer
- Amgen, Inc.
- Category
- Drug — Prescription Tablet
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 1157055
- Exp. Date 1/31/2028
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Amgen, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same brand · SENSIPAR
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01
Same manufacturer · Amgen, Inc.
See all →- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- HighInjectable Drug Recalled for Stability Issues at Expiration
FDA (Drugs) · 2025-03-26
- HighNeupogen Injectable Drug Recalled for Potential Stability Issues at Expiration
FDA (Drugs) · 2025-03-26
- HighMVASI Cancer Drug Recalled for Loose Container Crimp
FDA (Drugs) · 2022-05-18
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19